The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Bifidobacterium Lactis-Global Market Insights and Sales Trends 2025
Synopsis
Bifidobacterium lactis is a genus of Gram-positive, non-moving, rod-shaped cells, sometimes bifurcated at one end, and strictly anaerobic bacteria. It is a strain of probiotics isolated from healthy human intestines. Bifidobacterium subsp. lactis has good acid resistance, and has good tolerance to artificial gastric juice, intestinal juice and bile salts.
The global Bifidobacterium Lactis market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Bifidobacterium Lactis in various end use industries. The expanding demands from the Healthy Food, Dairy Products, Medical Industrial and Others, are propelling Bifidobacterium Lactis market. Bifidobacterium Bifidum, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Bifidobacterium Adolescentis segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Bifidobacterium Lactis market, driven by demand from China, the second largest economy with some signs of stabilising, the Bifidobacterium Lactis market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Bifidobacterium Lactis, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Bifidobacterium Lactis market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Bifidobacterium Lactis market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Bifidobacterium Lactis sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Bifidobacterium Lactis covered in this report include Chr Hansen, Lallemand, Nestle, Danone, Probi, BioGaia, Yakult, Novozymes and Pamex Pharmaceuticals, etc.
The global Bifidobacterium Lactis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Chr Hansen
Lallemand
Nestle
Danone
Probi
BioGaia
Yakult
Novozymes
Pamex Pharmaceuticals
Beijing Scitop Bio Tech
Wecare Probiotics
Global Bifidobacterium Lactis market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Bifidobacterium Lactis market, Segment by Type:
Bifidobacterium Bifidum
Bifidobacterium Adolescentis
Bifidobacterium Infantis
Bifidobacterium Breve
Bifidobacterium Longum
Global Bifidobacterium Lactis market, by Application
Healthy Food
Dairy Products
Medical Industrial
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Bifidobacterium Lactis manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Bifidobacterium Lactis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Bifidobacterium lactis is a genus of Gram-positive, non-moving, rod-shaped cells, sometimes bifurcated at one end, and strictly anaerobic bacteria. It is a strain of probiotics isolated from healthy human intestines. Bifidobacterium subsp. lactis has good acid resistance, and has good tolerance to artificial gastric juice, intestinal juice and bile salts.
The global Bifidobacterium Lactis market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Bifidobacterium Lactis in various end use industries. The expanding demands from the Healthy Food, Dairy Products, Medical Industrial and Others, are propelling Bifidobacterium Lactis market. Bifidobacterium Bifidum, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Bifidobacterium Adolescentis segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Bifidobacterium Lactis market, driven by demand from China, the second largest economy with some signs of stabilising, the Bifidobacterium Lactis market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Bifidobacterium Lactis, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Bifidobacterium Lactis market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Bifidobacterium Lactis market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Bifidobacterium Lactis sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Bifidobacterium Lactis covered in this report include Chr Hansen, Lallemand, Nestle, Danone, Probi, BioGaia, Yakult, Novozymes and Pamex Pharmaceuticals, etc.
The global Bifidobacterium Lactis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Chr Hansen
Lallemand
Nestle
Danone
Probi
BioGaia
Yakult
Novozymes
Pamex Pharmaceuticals
Beijing Scitop Bio Tech
Wecare Probiotics
Global Bifidobacterium Lactis market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Bifidobacterium Lactis market, Segment by Type:
Bifidobacterium Bifidum
Bifidobacterium Adolescentis
Bifidobacterium Infantis
Bifidobacterium Breve
Bifidobacterium Longum
Global Bifidobacterium Lactis market, by Application
Healthy Food
Dairy Products
Medical Industrial
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Bifidobacterium Lactis manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Bifidobacterium Lactis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Bifidobacterium Lactis Market Overview
1.1 Bifidobacterium Lactis Product Overview
1.2 Bifidobacterium Lactis Market Segment by Type
1.2.1 Bifidobacterium Bifidum
1.2.2 Bifidobacterium Adolescentis
1.2.3 Bifidobacterium Infantis
1.2.4 Bifidobacterium Breve
1.2.5 Bifidobacterium Longum
1.3 Global Bifidobacterium Lactis Market Size by Type
1.3.1 Global Bifidobacterium Lactis Market Size Overview by Type (2018-2029)
1.3.2 Global Bifidobacterium Lactis Historic Market Size Review by Type (2018-2023)
1.3.3 Global Bifidobacterium Lactis Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Bifidobacterium Lactis Sales Breakdown by Type (2018-2023)
1.4.2 Europe Bifidobacterium Lactis Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Bifidobacterium Lactis Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Bifidobacterium Lactis Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Bifidobacterium Lactis Sales Breakdown by Type (2018-2023)
2 Global Bifidobacterium Lactis Market Competition by Company
2.1 Global Top Players by Bifidobacterium Lactis Sales (2018-2023)
2.2 Global Top Players by Bifidobacterium Lactis Revenue (2018-2023)
2.3 Global Top Players by Bifidobacterium Lactis Price (2018-2023)
2.4 Global Top Manufacturers Bifidobacterium Lactis Manufacturing Base Distribution, Sales Area, Product Type
2.5 Bifidobacterium Lactis Market Competitive Situation and Trends
2.5.1 Bifidobacterium Lactis Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Bifidobacterium Lactis Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Bifidobacterium Lactis as of 2022)
2.7 Date of Key Manufacturers Enter into Bifidobacterium Lactis Market
2.8 Key Manufacturers Bifidobacterium Lactis Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Bifidobacterium Lactis Status and Outlook by Region
3.1 Global Bifidobacterium Lactis Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Bifidobacterium Lactis Historic Market Size by Region
3.2.1 Global Bifidobacterium Lactis Sales in Volume by Region (2018-2023)
3.2.2 Global Bifidobacterium Lactis Sales in Value by Region (2018-2023)
3.2.3 Global Bifidobacterium Lactis Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Bifidobacterium Lactis Forecasted Market Size by Region
3.3.1 Global Bifidobacterium Lactis Sales in Volume by Region (2024-2029)
3.3.2 Global Bifidobacterium Lactis Sales in Value by Region (2024-2029)
3.3.3 Global Bifidobacterium Lactis Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Bifidobacterium Lactis by Application
4.1 Bifidobacterium Lactis Market Segment by Application
4.1.1 Healthy Food
4.1.2 Dairy Products
4.1.3 Medical Industrial
4.1.4 Others
4.2 Global Bifidobacterium Lactis Market Size by Application
4.2.1 Global Bifidobacterium Lactis Market Size Overview by Application (2018-2029)
4.2.2 Global Bifidobacterium Lactis Historic Market Size Review by Application (2018-2023)
4.2.3 Global Bifidobacterium Lactis Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Bifidobacterium Lactis Sales Breakdown by Application (2018-2023)
4.3.2 Europe Bifidobacterium Lactis Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Bifidobacterium Lactis Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Bifidobacterium Lactis Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Bifidobacterium Lactis Sales Breakdown by Application (2018-2023)
5 North America Bifidobacterium Lactis by Country
5.1 North America Bifidobacterium Lactis Historic Market Size by Country
5.1.1 North America Bifidobacterium Lactis Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Bifidobacterium Lactis Sales in Volume by Country (2018-2023)
5.1.3 North America Bifidobacterium Lactis Sales in Value by Country (2018-2023)
5.2 North America Bifidobacterium Lactis Forecasted Market Size by Country
5.2.1 North America Bifidobacterium Lactis Sales in Volume by Country (2024-2029)
5.2.2 North America Bifidobacterium Lactis Sales in Value by Country (2024-2029)
6 Europe Bifidobacterium Lactis by Country
6.1 Europe Bifidobacterium Lactis Historic Market Size by Country
6.1.1 Europe Bifidobacterium Lactis Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Bifidobacterium Lactis Sales in Volume by Country (2018-2023)
6.1.3 Europe Bifidobacterium Lactis Sales in Value by Country (2018-2023)
6.2 Europe Bifidobacterium Lactis Forecasted Market Size by Country
6.2.1 Europe Bifidobacterium Lactis Sales in Volume by Country (2024-2029)
6.2.2 Europe Bifidobacterium Lactis Sales in Value by Country (2024-2029)
7 Asia-Pacific Bifidobacterium Lactis by Region
7.1 Asia-Pacific Bifidobacterium Lactis Historic Market Size by Region
7.1.1 Asia-Pacific Bifidobacterium Lactis Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Bifidobacterium Lactis Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Bifidobacterium Lactis Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Bifidobacterium Lactis Forecasted Market Size by Region
7.2.1 Asia-Pacific Bifidobacterium Lactis Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Bifidobacterium Lactis Sales in Value by Region (2024-2029)
8 Latin America Bifidobacterium Lactis by Country
8.1 Latin America Bifidobacterium Lactis Historic Market Size by Country
8.1.1 Latin America Bifidobacterium Lactis Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Bifidobacterium Lactis Sales in Volume by Country (2018-2023)
8.1.3 Latin America Bifidobacterium Lactis Sales in Value by Country (2018-2023)
8.2 Latin America Bifidobacterium Lactis Forecasted Market Size by Country
8.2.1 Latin America Bifidobacterium Lactis Sales in Volume by Country (2024-2029)
8.2.2 Latin America Bifidobacterium Lactis Sales in Value by Country (2024-2029)
9 Middle East and Africa Bifidobacterium Lactis by Country
9.1 Middle East and Africa Bifidobacterium Lactis Historic Market Size by Country
9.1.1 Middle East and Africa Bifidobacterium Lactis Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Bifidobacterium Lactis Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Bifidobacterium Lactis Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Bifidobacterium Lactis Forecasted Market Size by Country
9.2.1 Middle East and Africa Bifidobacterium Lactis Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Bifidobacterium Lactis Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Chr Hansen
10.1.1 Chr Hansen Company Information
10.1.2 Chr Hansen Introduction and Business Overview
10.1.3 Chr Hansen Bifidobacterium Lactis Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Chr Hansen Bifidobacterium Lactis Products Offered
10.1.5 Chr Hansen Recent Development
10.2 Lallemand
10.2.1 Lallemand Company Information
10.2.2 Lallemand Introduction and Business Overview
10.2.3 Lallemand Bifidobacterium Lactis Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Lallemand Bifidobacterium Lactis Products Offered
10.2.5 Lallemand Recent Development
10.3 Nestle
10.3.1 Nestle Company Information
10.3.2 Nestle Introduction and Business Overview
10.3.3 Nestle Bifidobacterium Lactis Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Nestle Bifidobacterium Lactis Products Offered
10.3.5 Nestle Recent Development
10.4 Danone
10.4.1 Danone Company Information
10.4.2 Danone Introduction and Business Overview
10.4.3 Danone Bifidobacterium Lactis Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Danone Bifidobacterium Lactis Products Offered
10.4.5 Danone Recent Development
10.5 Probi
10.5.1 Probi Company Information
10.5.2 Probi Introduction and Business Overview
10.5.3 Probi Bifidobacterium Lactis Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Probi Bifidobacterium Lactis Products Offered
10.5.5 Probi Recent Development
10.6 BioGaia
10.6.1 BioGaia Company Information
10.6.2 BioGaia Introduction and Business Overview
10.6.3 BioGaia Bifidobacterium Lactis Sales, Revenue and Gross Margin (2018-2023)
10.6.4 BioGaia Bifidobacterium Lactis Products Offered
10.6.5 BioGaia Recent Development
10.7 Yakult
10.7.1 Yakult Company Information
10.7.2 Yakult Introduction and Business Overview
10.7.3 Yakult Bifidobacterium Lactis Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Yakult Bifidobacterium Lactis Products Offered
10.7.5 Yakult Recent Development
10.8 Novozymes
10.8.1 Novozymes Company Information
10.8.2 Novozymes Introduction and Business Overview
10.8.3 Novozymes Bifidobacterium Lactis Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Novozymes Bifidobacterium Lactis Products Offered
10.8.5 Novozymes Recent Development
10.9 Pamex Pharmaceuticals
10.9.1 Pamex Pharmaceuticals Company Information
10.9.2 Pamex Pharmaceuticals Introduction and Business Overview
10.9.3 Pamex Pharmaceuticals Bifidobacterium Lactis Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Pamex Pharmaceuticals Bifidobacterium Lactis Products Offered
10.9.5 Pamex Pharmaceuticals Recent Development
10.10 Beijing Scitop Bio Tech
10.10.1 Beijing Scitop Bio Tech Company Information
10.10.2 Beijing Scitop Bio Tech Introduction and Business Overview
10.10.3 Beijing Scitop Bio Tech Bifidobacterium Lactis Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Beijing Scitop Bio Tech Bifidobacterium Lactis Products Offered
10.10.5 Beijing Scitop Bio Tech Recent Development
10.11 Wecare Probiotics
10.11.1 Wecare Probiotics Company Information
10.11.2 Wecare Probiotics Introduction and Business Overview
10.11.3 Wecare Probiotics Bifidobacterium Lactis Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Wecare Probiotics Bifidobacterium Lactis Products Offered
10.11.5 Wecare Probiotics Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Bifidobacterium Lactis Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Bifidobacterium Lactis Industrial Chain Analysis
11.4 Bifidobacterium Lactis Market Dynamics
11.4.1 Bifidobacterium Lactis Industry Trends
11.4.2 Bifidobacterium Lactis Market Drivers
11.4.3 Bifidobacterium Lactis Market Challenges
11.4.4 Bifidobacterium Lactis Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Bifidobacterium Lactis Distributors
12.3 Bifidobacterium Lactis Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
